Deepak Fertilisers & Petrochemicals will participate in two physical investor conferences in Mumbai this August, providing market participants with an opportunity to engage with company management. The engagements are scheduled for August 12, 2026, and August 19, 2026, as part of the company's compliance with disclosure regulations regarding analyst and investor interactions.

The company notified the Bombay Stock Exchange and the National Stock Exchange on August 7, 2026, detailing the schedule under Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rabindra Kumar Purohit, VP – Legal, Compliance & Company Secretary, signed the intimation.

Conference Schedule

The management team will attend the following events:

Both meetings are scheduled for Wednesdays. The company noted that the schedule is subject to change due to exigencies involving analysts, investors, or the company itself.

Disclosure Standards

Deepak Fertilisers confirmed that no Unpublished Price Sensitive Information (UPSI) will be shared during these meetings. This assurance aligns with regulatory requirements to maintain fair disclosure practices among all stakeholders. The details of these engagements have also been published on the company’s website, www.dfpcl.com , for broader accessibility.

What the Numbers Show

While no financial data was disclosed in this filing, the decision to engage in multiple high-profile investor conferences signals a proactive approach to corporate communication. Participation in both EMKAY Confluence and the Motilal Oswal Global Investor Conference allows the company to address a wide spectrum of domestic and international investors simultaneously. These platforms typically serve as venues for discussing strategic outlooks and operational updates without breaching UPSI norms.

Deepak Fertilisers & Petrochemicals delivered its strongest quarterly performance in company history during Q1FY27, reporting a record operating EBITDA of ₹845 crore and net profit after tax (PAT) of ₹490 crore. The results, discussed in an earnings conference call held on July 31, 2026, reflect a 65% year-on-year surge in EBITDA and a 101% jump in PAT, underpinned by robust pricing in mining and industrial chemicals and the initial benefits of its integrated gas-to-ammonia value chain. Consolidated revenue reached ₹3,256 crore, up 22% from the previous year and 8% quarter-on-quarter.

The filing was made pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Chairman and Managing Director Sailesh Mehta attributed the performance to three strategic pillars: the resilience of its integrated value chain anchored by a 15-year LNG contract with Equinor, alignment with India’s infrastructure and agricultural growth stories, and a shift toward specialty products that command price premiums. President and CFO Subhash Anand noted that the strong financials were achieved despite temporary volume disruptions in the mining chemical segment due to changes in the PESO portal guidelines.

Segment Performance

The mining chemical business remained resilient, generating revenue of approximately ₹911 crore, a 37% year-on-year increase, despite volumes settling at 130 kilotons due to logistical supply chain disturbances. The business-to-consumer (B2C) strategy gained traction, with B2C revenue growing 42% to ₹151 crore, contributing 17% of the segment’s total revenue. Industrial chemical revenue stood at around ₹490 crore, supported by stable nitric acid volumes and improved pharma-grade demand for isophthalic acid (IPA), although IPA volumes faced constraints from limited propylene availability. Crop nutrition revenue rose 9% year-on-year to approximately ₹1,367 crore, driven by a 4% growth in manufactured NPK sales and steady performance from CropTek, which now accounts for 43% of the segment’s revenue.

Balance Sheet and Capital Expenditure

Despite incurring over ₹500 crore in capital expenditure during the quarter, Deepak Fertilisers strengthened its balance sheet. Net debt reduced to ₹4,719 crore, bringing the debt-to-EBITDA ratio down from 2.86x to 1.4x. Total spending on strategic growth projects reached approximately ₹3,850 crore as of Q1. The Gopalpur TAN project is 96% complete, and the Dahej nitric acid project is 93% complete, with both expected to commence operations in Q2FY27. Management confirmed that both projects remain within their approved capex envelopes and are on schedule for commissioning.

A significant milestone was the commencement of LNG supplies under the long-term agreement with Equinor, with the first cargo received in May. This integration enhances supply security and cost visibility. Approximately 80% of the ammonia produced is consumed captive, with the surplus sold in the merchant market. The ammonia plant has been debottlenecked, achieving an average utilization of 94% in the quarter, up from previous constraints.

What the Numbers Show

The divergence between volume trends and margin expansion highlights the structural shift in Deepak Fertilisers’ profitability drivers. While mining chemical volumes were lower at 130 kilotons and IPA volumes faced propylene constraints, the overall EBITDA margin expanded to 26% from 19% in the same quarter last year. This indicates that pricing power and cost optimization through the Equinor LNG contract are now outweighing volume headwinds. Furthermore, the rapid improvement in the debt-to-EBITDA ratio to 1.4x, despite peak capex spending, demonstrates strong operational cash generation, positioning the company for deleveraging once the new capacities come online in Q4FY27.